Review Article

The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance

Table 2

Nrf2 and HO-1 upregulation in tumours.

Type of tumorNrf2HO-1Reference

Glioblastoma stem cells (GSCs)[101]
Lung cancer (NSCLC)[92, 94]
Ovarian carcinoma[85]

Bladder cancer[121]
Chronic myeloid leukemia[139]
Colon adenocarcinoma[135]
Colorectal cancer[118]
Fibrosarcoma[131]
Gastric cancer[138]
Hepatocellular carcinoma (HCC)[127]
Kaposi sarcoma[128]
Lung cancer (NSCLC)[120, 122, 134, 137]
Melanoma[123, 131]
Oral squamous cell carcinoma[125]
Pancreatic cancer[119, 124, 126, 133]

Breast cancer[86]
Cervical cancer[152]
Chronic myeloid leukemia[136]
Esophageal squamous carcinoma[82]
Gallbladder cancer[79]
Glioblastoma[100, 155]
Glioblastoma stem cells (GSCs)[100]
Hepatoma[152]
Lung cancer (NSCLC)[87, 89, 152]
Malignant B lymphocytes[154]
Mammosphere stem cells (MSC)[102]
Multiple myeloma[153]
Neuroblastoma[90, 91]
Ovarian carcinoma cells[156]
Prostate cancer[88]
Renal cancer[117]